FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1179524006: Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4651602015 Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4651603013 Product containing lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form est un(e) (attribut) Product containing lidocaine and metronidazole and sucralfate (medicinal product) true Inferred relationship Some
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form est un(e) (attribut) Product containing metronidazole in cutaneous dose form (medicinal product form) true Inferred relationship Some
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form est un(e) (attribut) Lidocaine-containing product in cutaneous dose form true Inferred relationship Some
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form a une forme pharmaceutique (attribut) forme cutanée true Inferred relationship Some
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form a pour principe actif (attribut) Metronidazole (substance) true Inferred relationship Some 1
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form a pour principe actif (attribut) Sucralfate (substance) true Inferred relationship Some 2
Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form a pour principe actif (attribut) Lidocaine (substance) true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only lidocaine and metronidazole and sucralfate in cutaneous dose form (medicinal product form) est un(e) (attribut) True Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Inferred relationship Some
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream est un(e) (attribut) True Lidocaine- and metronidazole- and sucralfate-containing product in cutaneous dose form Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

Back to Start